Mechanism of the anti-angiogenic effect of Avemar on tumor cells

  • Authors:
    • Nilüfer Gülmen Imir
    • Esra Aydemir
    • Ece Şimşek
  • View Affiliations

  • Published online on: December 13, 2017     https://doi.org/10.3892/ol.2017.7604
  • Pages: 2673-2678
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Avemar, a derivative of fermented wheat germ extract, is a non‑toxic and natural compound that is used as a dietary supplement by cancer patients undergoing chemotherapy and radiotherapy. Avemar has numerous biological activities, and several recent studies have reported that it may also have metastatic and anti‑angiogenic effects. In the present study, the mechanism of the anti‑angiogenic effect of Avemar on human cancer cells was investigated. The human cell lines NCI‑N87 (gastric tubular adenocarcinoma), PC3 (prostate carcinoma), HeLa (endocervical adenocarcinoma) and A549 (lung adenocarcinoma) were treated with various doses (400, 800, 1,600 and 3,200 µg/ml) of Avemar, and the changes in mRNA and protein levels of two important markers of angiogenesis, vascular endothelial growth factor (VEGF) and cyclooxygenase‑2 (Cox‑2), were assessed by reverse transcription‑quantitative polymerase chain reaction and ELISA. VEGF and Cox‑2 protein and mRNA levels were significantly lower in Avemar‑treated cells than in untreated cells. The data suggest that Avemar may exert an anti‑angiogenic effect on cancer cells. Thus, it is suggested to medical doctors as a potential agent for the anti‑angiogenic treatment of cancer.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Imir, N.G., Aydemir, E., & Şimşek, E. (2018). Mechanism of the anti-angiogenic effect of Avemar on tumor cells. Oncology Letters, 15, 2673-2678. https://doi.org/10.3892/ol.2017.7604
MLA
Imir, N. G., Aydemir, E., Şimşek, E."Mechanism of the anti-angiogenic effect of Avemar on tumor cells". Oncology Letters 15.2 (2018): 2673-2678.
Chicago
Imir, N. G., Aydemir, E., Şimşek, E."Mechanism of the anti-angiogenic effect of Avemar on tumor cells". Oncology Letters 15, no. 2 (2018): 2673-2678. https://doi.org/10.3892/ol.2017.7604